|
|||||
|
|
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer |
|
| Authors: | Ravi A. Madan Fatima H. Karzai Munjid Al Harthy Daniel P. Petrylak Joseph W. Kim Philip M. Arlen Inger Rosner Marc R. Theoret Lisa Cordes Marijo Bilusic Cody J. Peer Nancy A. Dawson Anna Couvillon Amy Hankin Moniquea Williams Guin Chun Helen Owens Jennifer L. Marte Min-Jung Lee Yusuke Tomita Akira Yuno Jane B. Trepel Sunmin Lee Seth M. Steinberg James L. Gulley William D. Figg William L. Dahut |
| Affiliation: | 1. Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA;2. Yale School of Medicine, New Haven, CT, USA;3. Center for Prostate Disease Research, Walter Reed National Military Medical Center, Bethesda, MD, USA;4. Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA;5. Developmental Therapeutics Branch, NCI, Bethesda, MD, USA;6. Biostatistics and Data Management Section, Center for Cancer Research, NCI, Bethesda, MD, USA |
| Abstract: | |
| Keywords: | prostate cancer metastatic prostate cancer chemotherapy combination therapy #PCSM #ProstateCancer #uroonc |